Innovative Therapies Will Require Innovations in Financing and Regulations WASHINGTON, DC, February 12—Today, the MIT-based Financing and Reimbursement of Cures in the US (FoCUS) consortium released a series of large-scale … Read More
“Dynamic Dossier in the Cloud” to Transform Data Sharing, Starting with Federal Regulators
New platform will redefine biopharmaceutical data sharingMIT NEWDIGS and the Harvard-MIT Center for Regulatory Science announced the Dynamic Dossier in the Cloud today, a radical new platform that promises to … Read More
MIT LEAPS Design Lab Shapes Blueprint for Rheumatoid Arthritis Pilot in Massachusetts
CAMBRIDGE, MASSACHUSETTS — An international community of biomedical and healthcare innovation leaders gathered at MIT on December 12 and 13 for the second Design Lab for LEAPS (Learning Ecosystems Accelerator … Read More
NPR: “A Search For New Ways To Pay For Drugs That Cost A Mint”
Installment plans and refunds for treatments that don’t work are two options getting more attention as ultra-expensive therapies become more common. The financial strains will only grow. Read and hear … Read More
FasterCures joins NEWDIGS Initiative at MIT as a Strategic Partner
Collaboration to drive innovation across healthcare ecosystem CAMBRIDGE, MA, 21 SEPTEMBER 2018–FasterCures, a center of the Milken Institute devoted to saving lives by speeding up and improving the medical research … Read More
FoCUS Research Team interviewed for article on Innovating Payment Models
The leads of the FoCUS Research Teams, Strategic Director Mark Trusheim, Research Advisor Casey Quinn, Director of Simulation & Policy Research Daniel Mytelka, and Director of Drug Development Pipeline Research … Read More
LEAPS Announces Disease Area for Pilot Project
Participants in the first LEAPS Design Lab in July 2018 were tasked with considering disease areas offering the prospect of significant healthcare impact and identifying early practical and technical challenges … Read More
LEAPS project at MIT aims to pilot “learning ecosystem” for patient-centered biomedical innovation
New initiative aims to improve decision-making across biopharmaceutical development and delivery lifecycle CAMBRIDGE, 23 July 2018—The NEWDIGS Initiative at the Massachusetts Institute of Technology (MIT) hosted a Design Lab … Read More
FoCUS responds to HHS “Blueprint” Request for Information
Federal initiative seeks to make access to innovative therapies wider and more financially sustainable On May 16, 2018 the US Department of Health and Human Services (HHS) published a … Read More
PPD, Evidera join NEWDIGS Initiative at MIT as a Strategic Partner
Collaboration to drive innovation across health care ecosystem WILMINGTON, N.C., May 22, 2018– Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute … Read More